Skip to main content

Table 3 HPV genotyping of discordant samples with the LiPA Extra test

From: Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens

HPV Genotype HPV classification HC2-ve RT + ve (N) RT-ve HC2 + ve (N) Histology CIN3+ (HC2-ve/RT-ve)
HPV 16a HR 2 1 0
HPV 18a HR 0 3 0
HPV 31a HR 0 6 0/2
HPV 33a HR 0 0 0
HPV 39a HR 0 1 0
HPV 45a HR 2 0 0
HPV 51a HR 4 3 0
HPV 52a HR 0 4 0
HPV 56a HR 0 1 0
HPV 58a HR 0 1 0
HPV 59a HR 1 0 0
HPV 68a HR 0 0 0
HPV 53 Intermediate 0 11 0
HPV 66b Intermediate 0 1 0
HPV 70 Intermediate 0 2 0
HPV 6 LR 0 1 0
HPV 54 LR 0 1 0
HPV 74   1 1 0
HPVX   0 2 0
HPV DNA -ve   7 5 0
no result
(sample failed)
  1 3 0
Total   18 47 0/2
  1. a HC2 and RT target types; b RT target type; HC2, Digene Hybrid Capture 2 High-Risk HPV DNA test, RT, Abbott RealTime High Risk HPV Test, HPVX HPV DNA was detected by LiPA, but could not be correlated to a specific type; HR High-risk, LR Low-risk; +ve: positive; −ve: negative; +: and worse